Prevalence, risk and genetic characteristics of drug-resistant tuberculosis in a tertiary care tuberculosis hospital in China

References

• World Health Organization. Global tuberculosis report 2014. WHO/HTM/TB/2014.8. Geneva (Switzerland): World Health Organization: 2014.
   Google Scholar
• Zhao Y, Xu S, Wang L, et al. National survey of drug-resistant tuberculosis in China. N Engl J Med. 2012;366(23):2161–2170. doi:10.1056/NEJMoa110878922670902
   PubMed Web of Science ®Google Scholar
• Gandhi NR, Nunn P, Dheda K, et al. Multidrug-resistant and extensively drug-resistant tuberculosis: a threat to global control of tuberculosis. Lancet. 2010;375(9728):1830–1843. doi:10.1016/S0140-6736(10)60410-220488523
   PubMed Web of Science ®Google Scholar
• Afanas’ev MV, Ikryannikova LN, Il’ina EN, et al. Molecular characteristics of rifampicin- and isoniazid-resistant Mycobacterium tuberculosis isolates from the Russian Federation. J Antimicrob Chemother. 2007;59(6):1057–1064. doi:10.1093/jac/dkm08617442757
   PubMed Web of Science ®Google Scholar
• He GX, Zhao YL, Jiang GL, et al. Prevalence of tuberculosis drug resistance in 10 provinces of China. BMC Infect Dis. 2008;8:166. doi:10.1186/1471-2334-8-16619077223
   PubMed Web of Science ®Google Scholar
• Ramazanzadeh R, Farnia P, Amirmozafari N, et al. Comparison between molecular epidemiology, geographical regions and drug resistance in Mycobacterium tuberculosis strains isolated from Iranian and Afghan patients. Chemotherapy. 2006;52(6):316–320. doi:10.1159/00009597117008783
   PubMed Web of Science ®Google Scholar
• Zhao LL, Chen Y, Liu HC, et al. Molecular characterization of multidrug-resistant Mycobacterium tuberculosis isolates from China. Antimicrob Agents Chemother. 2014;58(4):1997–2005. doi:10.1128/AAC.01792-1324419342
   PubMed Web of Science ®Google Scholar
• Zignol M, Wright A, Jaramillo E, Nunn P, Raviglione MC. Patients with previously treated tuberculosis no longer neglected. Clin Infect Dis. 2007;44(1):61–64. doi:10.1086/50932817143816
   PubMed Web of Science ®Google Scholar
• Zhao LL, Chen Y, Chen ZN, et al. Prevalence and molecular characteristics of drug-resistant Mycobacterium tuberculosis in Hunan, China. Antimicrob Agents Chemother. 2014;58(6):3475–3480. doi:10.1128/AAC.02426-1424733464
   PubMed Web of Science ®Google Scholar
• WHO. Policy guidance on TB drug susceptibility testing (DST) of second-line drugs. WHO/HTM/TB/2008392. Geneva (Switzerland): WHO; 2008.
   Google Scholar
• Guidelines for surveillance of drug resistance in tuberculosis. WHO Geneva/IUATLD Paris. International Union Against Tuberculosis and Lung Disease. Int J Tuberc Lung Dis. 1998;2(1):72–89.9562116
   PubMedGoogle Scholar
• Somerville W, Thibert L, Schwartzman K, Behr MA. Extraction of Mycobacterium tuberculosis DNA: a question of containment. J Clin Microbiol. 2005;43(6):2996–2997. doi:10.1128/JCM.43.6.2996-2997.200515956443
   PubMed Web of Science ®Google Scholar
• Kamerbeek J, Schouls L, Kolk A, et al. Simultaneous detection and strain differentiation of Mycobacterium tuberculosis for diagnosis and epidemiology. J Clin Microbiol. 1997;35(4):907–914.9157152
   PubMed Web of Science ®Google Scholar
• Wada T, Iwamoto T, Maeda S. Genetic diversity of the Mycobacterium tuberculosis Beijing family in East Asia revealed through refined population structure analysis. FEMS Microbiol Lett. 2009;291(1):35–43. doi:10.1111/j.1574-6968.2008.01431.x19054072
   PubMed Web of Science ®Google Scholar
• Zhao LL, Sun Q, Zeng CY, et al. Molecular characterisation of extensively drug-resistant Mycobacterium tuberculosis isolates in China. Int J Antimicrob Agents. 2015;45(2):137–143. doi:10.1016/j.ijantimicag.2014.09.01825465521
   PubMed Web of Science ®Google Scholar
• Qi YC, Ma MJ, Li DJ, et al. Multidrug-resistant and extensively drug-resistant tuberculosis in multi-ethnic region, Xinjiang Uygur Autonomous Region, China. PLoS One. 2012;7(2):e32103. doi:10.1371/journal.pone.003210322384153
   PubMed Web of Science ®Google Scholar
• Yuan X, Zhang T, Kawakami K, et al. Genotyping and clinical characteristics of multidrug and extensively drug-resistant tuberculosis in a tertiary care tuberculosis hospital in China. BMC Infect Dis. 2013;13:315. doi:10.1186/1471-2334-13-31523849244
   PubMed Web of Science ®Google Scholar
• Lan Y, Li Y, Chen L, Zhang J, Zhang H. Drug resistance profiles and trends in drug-resistant tuberculosis at a major hospital in Guizhou Province of China. Infect Drug Resist. 2019;12:211–219. doi:10.2147/IDR.S18853830666136
   PubMed Web of Science ®Google Scholar
• Liu Y, Jiang X, Li W, Zhang X, Wang W, Li C. The study on the association between Beijing genotype family and drug susceptibility phenotypes of Mycobacterium tuberculosis in Beijing. Sci Rep. 2017;7(1):15076. doi:10.1038/s41598-017-14119-z29118425
   PubMed Web of Science ®Google Scholar
• Deng Y, Wang Y, Wang J, et al. Laboratory-based surveillance of extensively drug-resistant tuberculosis, China. Emerg Infect Dis. 2011;17(3):495–497. doi:10.3201/eid1703.10081221392442
   PubMed Web of Science ®Google Scholar
• Tang S, Zhang Q, Yu J, et al. Extensively drug-resistant tuberculosis, China. Emerg Infect Dis. 2011;17(3):558–560. doi:10.3201/eid1703.10091921392462
   PubMed Web of Science ®Google Scholar
• Wang J, Liu Y, Zhang CL, et al. Genotypes and characteristics of clustering and drug susceptibility of Mycobacterium tuberculosis isolates collected in Heilongjiang Province, China. J Clin Microbiol. 2011;49(4):1354–1362. doi:10.1128/JCM.02274-1021325562
   PubMed Web of Science ®Google Scholar
• Liu Q, Yang D, Xu W, et al. Molecular typing of Mycobacterium tuberculosis isolates circulating in Jiangsu province, China. BMC Infect Dis. 2011;11:288. doi:10.1186/1471-2334-11-20822026819
   PubMed Web of Science ®Google Scholar
• Tanveer M, Hasan Z, Siddiqui AR, et al. Genotyping and drug resistance patterns of M. tuberculosis strains in Pakistan. BMC Infect Dis. 2008;8:171. doi:10.1186/1471-2334-8-17119108722
   PubMed Web of Science ®Google Scholar
• Ghebremichael S, Groenheit R, Pennhag A, et al. Drug resistant Mycobacterium tuberculosis of the Beijing genotype does not spread in Sweden. PLoS One. 2010;5(5):e10893. doi:10.1371/journal.pone.001089320531942
   PubMed Web of Science ®Google Scholar
• Alonso M, Alonso Rodriguez N, Garzelli C, et al. Characterization of Mycobacterium tuberculosis Beijing isolates from the Mediterranean area. BMC Microbiol. 2010;10:151. doi:10.1186/1471-2180-10-15120500810
   PubMed Web of Science ®Google Scholar
• Islam MM, Hameed HMA, Mugweru J, et al. Drug resistance mechanisms and novel drug targets for tuberculosis therapy. J Genet Genomics. 2017;44(1):21–37. doi:10.1016/j.jgg.2016.10.00228117224
   PubMed Web of Science ®Google Scholar
• Campbell PJ, Morlock GP, Sikes RD, et al. Molecular detection of mutations associated with first- and second-line drug resistance compared with conventional drug susceptibility testing of Mycobacterium tuberculosis. Antimicrob Agents Chemother. 2011;55(5):2032–2041. doi:10.1128/AAC.01550-1021300839
   PubMed Web of Science ®Google Scholar
• Wade MM, Zhang Y. Mechanisms of drug resistance in Mycobacterium tuberculosis. Front Biosci. 2004;9:975–994.14766424
   PubMed Web of Science ®Google Scholar
• Yuan X, Zhang T, Kawakami K, et al. Molecular characterization of multidrug- and extensively drug-resistant Mycobacterium tuberculosis strains in Jiangxi, China. J Clin Microbiol. 2012;50(7):2404–2413. doi:10.1128/JCM.06860-1122553245
   PubMed Web of Science ®Google Scholar
• Zhang Z, Lu J, Liu M, et al. Genotyping and molecular characteristics of multidrug-resistant Mycobacterium tuberculosis isolates from China. J Infect. 2015;70(4):335–345. doi:10.1016/j.jinf.2014.11.00825485999
   PubMed Web of Science ®Google Scholar
• Zhao LL, Liu HC, Sun Q, et al. Identification of mutations conferring streptomycin resistance in multidrug-resistant tuberculosis of China. Diagn Microbiol Infect Dis. 2015;83(2):150–153. doi:10.1016/j.diagmicrobio.2015.06.02026254141
   PubMed Web of Science ®Google Scholar
• Sun H, Zhang C, Xiang L, et al. Characterization of mutations in streptomycin-resistant Mycobacterium tuberculosis isolates in Sichuan, China and the association between Beijing-lineage and dual-mutation in gidB. Tuberculosis. 2016;96:102–106. doi:10.1016/j.tube.2015.09.00426786661
   PubMed Web of Science ®Google Scholar
• Shi R, Zhang J, Li C, Kazumi Y, Sugawara I. Detection of streptomycin resistance in Mycobacterium tuberculosis clinical isolates from China as determined by denaturing HPLC analysis and DNA sequencing. Microbes Infect. 2007;9(14–15):1538–1544. doi:10.1016/j.micinf.2007.08.00918023388
   PubMed Web of Science ®Google Scholar
• Chen Q, Pang Y, Liang Q, et al. Molecular characteristics of MDR Mycobacterium tuberculosis strains isolated in Fujian, China. Tuberculosis. 2014;94(2):159–161. doi:10.1016/j.tube.2013.03.00424325872
   PubMed Web of Science ®Google Scholar
• Unissa AN, Subbian S, Hanna LE, Selvakumar N. Overview on mechanisms of isoniazid action and resistance in Mycobacterium tuberculosis. Infect Genet Evol. 2016;45:474–492. doi:10.1016/j.meegid.2016.09.00427612406
   PubMed Web of Science ®Google Scholar
• Rinder H, Thomschke A, Rusch-Gerdes S, et al. Significance of ahpC promoter mutations for the prediction of isoniazid resistance in Mycobacterium tuberculosis. Eur J Clin Microbiol Infect Dis. 1998;17(7):508–511.9764555
   PubMed Web of Science ®Google Scholar
• Slayden RA, Barry CE 3rd. The genetics and biochemistry of isoniazid resistance in mycobacterium tuberculosis. Microbes Infect. 2000;2(6):659–669. doi:10.1016/S1286-4579(00)00359-210884617
   PubMed Web of Science ®Google Scholar